During the initial stage of type 1 diabetes, β-cells are exposed to the proinflammatory cytokines, such as IL-1β, IFN-γ, and TNF-α, released by the infiltrated immune cells [17–20]. The gene discussed is IL1B; the disease is type 1 diabetes mellitus.